Syneos Health (FRA:8IN) 3-Year EBITDA Growth Rate : 13.10% (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Syneos Health 3-Year EBITDA Growth Rate?

Syneos Health's EBITDA per Share for the three months ended in Jun. 2023 was €0.87.

During the past 12 months, Syneos Health's average EBITDA Per Share Growth Rate was -29.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 13.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 25.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 20.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Syneos Health was 66.20% per year. The lowest was 5.10% per year. And the median was 13.10% per year.

Competitive Comparison of Syneos Health's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Syneos Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syneos Health's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Syneos Health's 3-Year EBITDA Growth Rate falls into.

Syneos Health 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Syneos Health (FRA:8IN) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Syneos Health 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Syneos Health's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneos Health (FRA:8IN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (FRA:8IN) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1030 Sync Street, Morrisville, NC, USA, 27560-5468

Website

https://www.syneoshealth.com

Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Syneos Health (FRA:8IN) Headlines

No Headlines